Page last updated: 2024-08-22

cupric chloride and ER-Negative PR-Negative HER2-Negative Breast Cancer

cupric chloride has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Mohsen, MA; Helal, MA; Toson, EA1
An, H; Cho, TM; Cho, Y; Kim, JY; Kim, YJ; Lee, N; Oh, E; Seo, JH; Sung, D1

Other Studies

2 other study(ies) available for cupric chloride and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)-nicotinate complex.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:3

    Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Copper; Female; Gene Expression; Humans; Niacin; Phosphorylation; Programmed Cell Death 1 Receptor; Superoxide Dismutase; Survivin; Triple Negative Breast Neoplasms

2019
Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Cancer letters, 2017, 02-01, Volume: 386

    Topics: Animals; Anoikis; Antineoplastic Agents; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Copper; Cytoskeleton; Disulfiram; Dose-Response Relationship, Drug; Enzyme Activation; Female; Focal Adhesions; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Proteolysis; Signal Transduction; Time Factors; Triple Negative Breast Neoplasms; Tumor Burden; Vimentin; Xenograft Model Antitumor Assays

2017